Chronic lymphocytic leukaemia trials in Belarus

1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.

  Where

  Vitebsk

  Age

  18 years and over

  People

  24

  Run by

  Vitebsk Regional Clinical Cancer Centre

  See details and how to joinNCT06762431